Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Boots owner spends £54m on redundancy-related costs

Walgreens Boots Alliance declined to confirm how much of the money was paid to former Boots UK employees

Walgreens Boots Alliance has spent £54 million ($83m) on redundancies and related costs in three months, the company has revealed.

The global health and beauty giant has spent £353.2m ($542m) on its cost-saving programme since it announced the plan in August 2014, it said. The programme is intended to save £975m ($1.5bn) by 2017 through measures including axing around 700 non-store based roles in the UK and closing 200 US stores.

The company has now achieved "more than half of the programme's expected savings", with 84 US stores already closed, Walgreens Boots Alliance revealed in its latest financial report on Wednesday (October 28). 

The company told C+D it could not confirm how much of the £54m, spent on “severance and other business transition and exit costs” between June and August, relates to Boots UK redundancies. The company spent £22m specifcally on redundancies between March and May, it revealed in July. 

Pharmacy and wholesale divisions report increases

The company’s retail pharmacy international division, which includes Boots, reported sales of £2.3bn ($3.5bn) between June and August, a 4.3% rise on the same period last year, it said this week. Its wholesale division, which mainly consists of Alliance Healthcare, reported sales of £3.8bn ($5.8bn), 5% higher than the same period last year, it said.

Walgreens Boots Alliance reported overall sales of £18.6bn ($28.5bn) for the three-month period, it added. The company also announced its acquisition of fellow US pharmacy giant Rite Aid in a £11.2bn ($17.2bn) deal this week.

Walgreens Boots Alliance CEO Stefano Pessina said the company is “pleased with our progress” in its first fiscal year since its buyout of Alliance Boots in December 2014. But he stressed there is still “much work to do...in some challenging markets”.

Boots told C+D in June that the 700 UK job losses would take place over the next two to three years and could affect staff involved in Boots’ HR, finance, marketing, trading and operations teams across the UK and Ireland, as well employees at its Nottingham head office.


How do you think Walgreens Boots Alliance's financial results will affect its UK pharmacists?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD007797

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel